These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15649963)

  • 21. Improving coverage and scale-up of HIV prevention, treatment and care for injecting drug users: moving the agenda forward.
    Sharma M; Burrows D; Bluthenthal RN
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S1-4. PubMed ID: 18262403
    [No Abstract]   [Full Text] [Related]  

  • 22. What you think you know can hurt you: perceptual biases about HIV risk in intimate relationships.
    Harman JJ; O'Grady MA; Wilson K
    AIDS Behav; 2009 Apr; 13(2):246-57. PubMed ID: 18080101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thailand beats the odds in completing vaccine test.
    Cohen J
    Science; 2003 Sep; 301(5640):1663. PubMed ID: 14500958
    [No Abstract]   [Full Text] [Related]  

  • 24. Some neglected and emerging factors in HIV transmission in Ethiopia.
    Kloos H; Mariam DH
    Ethiop Med J; 2007 Jan; 45(1):103-7. PubMed ID: 17642165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends in HIV related risk behaviors. Some good news.
    Kandel I; Merrick J
    Int J Adolesc Med Health; 2006; 18(4):559-60. PubMed ID: 17340847
    [No Abstract]   [Full Text] [Related]  

  • 26. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes.
    Bruneau J; Daniel M; Kestens Y; Zang G; Généreux M
    J Epidemiol Community Health; 2008 Sep; 62(9):804-10. PubMed ID: 18701731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iran bans tattoos.
    IAPAC Mon; 2001 Feb; 7(2):40. PubMed ID: 11302020
    [No Abstract]   [Full Text] [Related]  

  • 28. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
    Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions.
    Kalichman SC
    Psychosom Med; 2008 Jun; 70(5):593-7. PubMed ID: 18519882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NIDA campaign to raise awareness of drug abuse--HIV connection.
    Am Fam Physician; 2006 Jan; 73(1):22. PubMed ID: 16417060
    [No Abstract]   [Full Text] [Related]  

  • 31. Sexual risk behavior among injection drug users before widespread availability of highly active antiretroviral therapy.
    Rusch ML; Farzadegan H; Tarwater PM; Safaeian M; Vlahov D; Strathdee SA
    AIDS Behav; 2005 Sep; 9(3):289-99. PubMed ID: 16133905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safe injection sites.
    HIV Prev Plus; 2002; 3(3):3. PubMed ID: 16456970
    [No Abstract]   [Full Text] [Related]  

  • 34. Predicting HIV transmission risk among HIV-infected patients seen in clinical settings.
    Morin SF; Myers JJ; Shade SB; Koester K; Maiorana A; Rose CD
    AIDS Behav; 2007 Sep; 11(5 Suppl):S6-16. PubMed ID: 17577655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exchanging ideas.
    Lyall J
    Nurs Times; 1991 Jul 31-Aug 6; 87(31):20-1. PubMed ID: 1866293
    [No Abstract]   [Full Text] [Related]  

  • 36. Unmet need for recommended preventive health services among clients of California syringe exchange programs: implications for quality improvement.
    Heinzerling KG; Kral AH; Flynn NM; Anderson RL; Scott A; Gilbert ML; Asch SM; Bluthenthal RN
    Drug Alcohol Depend; 2006 Feb; 81(2):167-78. PubMed ID: 16043308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials.
    Crepaz N; Lyles CM; Wolitski RJ; Passin WF; Rama SM; Herbst JH; Purcell DW; Malow RM; Stall R;
    AIDS; 2006 Jan; 20(2):143-57. PubMed ID: 16511407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Needle-sharing among young IV drug users and their social network members: The influence of the injection partner's characteristics on HIV risk behavior.
    Unger JB; Kipke MD; De Rosa CJ; Hyde J; Ritt-Olson A; Montgomery S
    Addict Behav; 2006 Sep; 31(9):1607-18. PubMed ID: 16459023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants.
    Disney E; Kidorf M; Kolodner K; King V; Peirce J; Beilenson P; Brooner RK
    J Nerv Ment Dis; 2006 Aug; 194(8):577-83. PubMed ID: 16909065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, China.
    Zhang Y; Shan H; Trizzino J; Ruan Y; Beauchamp G; Mâsse B; Ma J; Gu Y; He Y; Rui B; Wang J; Poundstone K; Jiang Y; Brooks Jackson J; Shao Y
    J Infect; 2007 Mar; 54(3):285-90. PubMed ID: 16831464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.